BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23613753)

  • 1. Towards estimation of HIV-1 date of infection: a time-continuous IgG-model shows that seroconversion does not occur at the midpoint between negative and positive tests.
    Skar H; Albert J; Leitner T
    PLoS One; 2013; 8(4):e60906. PubMed ID: 23613753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes.
    Parekh BS; Hanson DL; Hargrove J; Branson B; Green T; Dobbs T; Constantine N; Overbaugh J; McDougal JS
    AIDS Res Hum Retroviruses; 2011 Mar; 27(3):265-73. PubMed ID: 20954834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion.
    Dobbs T; Kennedy S; Pau CP; McDougal JS; Parekh BS
    J Clin Microbiol; 2004 Jun; 42(6):2623-8. PubMed ID: 15184443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends of HIV-1 incidence with credible intervals in Sweden 2002-09 reconstructed using a dynamic model of within-patient IgG growth.
    Romero-Severson EO; Lee Petrie C; Ionides E; Albert J; Leitner T
    Int J Epidemiol; 2015 Jun; 44(3):998-1006. PubMed ID: 26163684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay.
    Laeyendecker O; Brookmeyer R; Oliver AE; Mullis CE; Eaton KP; Mueller AC; Jacobson LP; Margolick JB; Brown J; Rinaldo CR; Quinn TC; Eshleman SH;
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):816-22. PubMed ID: 22014036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence.
    Parekh BS; Kennedy MS; Dobbs T; Pau CP; Byers R; Green T; Hu DJ; Vanichseni S; Young NL; Choopanya K; Mastro TD; McDougal JS
    AIDS Res Hum Retroviruses; 2002 Mar; 18(4):295-307. PubMed ID: 11860677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay.
    Hu DJ; Vanichseni S; Mock PA; Young NL; Dobbs T; Byers RH; Choopanya K; van Griensven F; Kitayaporn D; McDougal JS; Tappero JW; Mastro TD; Parekh BS
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):727-30. PubMed ID: 14585202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.
    Janssen RS; Satten GA; Stramer SL; Rawal BD; O'Brien TR; Weiblen BJ; Hecht FM; Jack N; Cleghorn FR; Kahn JO; Chesney MA; Busch MP
    JAMA; 1998 Jul; 280(1):42-8. PubMed ID: 9660362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA testing for diagnosis of retroviral infections in the Caribbean.
    Ridel PR; Artus JC; Capron A
    Bull Pan Am Health Organ; 1991; 25(3):201-6. PubMed ID: 1742565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More reliable diagnosis of infection with human immunodeficiency virus type 1 (HIV-1) by detection of antibody IgGs to pol and gag proteins of HIV-1 and p24 antigen of HIV-1 in urine, saliva, and/or serum with highly sensitive and specific enzyme immunoassay (immune complex transfer enzyme immunoassay): a review.
    Hashida S; Hashinaka K; Ishikawa S; Ishikawa E
    J Clin Lab Anal; 1997; 11(5):267-86. PubMed ID: 9292394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Better control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection.
    Novitsky V; Wang R; Kebaabetswe L; Greenwald J; Rossenkhan R; Moyo S; Musonda R; Woldegabriel E; Lagakos S; Essex M
    J Acquir Immune Defic Syndr; 2009 Oct; 52(2):265-72. PubMed ID: 19525854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay.
    Hayashida T; Gatanaga H; Tanuma J; Oka S
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):495-8. PubMed ID: 18327979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How should we best estimate the mean recency duration for the BED method?
    Hargrove J; Eastwood H; Mahiane G; van Schalkwyk C
    PLoS One; 2012; 7(11):e49661. PubMed ID: 23166743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing.
    Bärnighausen T; Wallrauch C; Welte A; McWalter TA; Mbizana N; Viljoen J; Graham N; Tanser F; Puren A; Newell ML
    PLoS One; 2008; 3(11):e3640. PubMed ID: 18982059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of acute infections during HIV testing in North Carolina.
    Pilcher CD; Fiscus SA; Nguyen TQ; Foust E; Wolf L; Williams D; Ashby R; O'Dowd JO; McPherson JT; Stalzer B; Hightow L; Miller WC; Eron JJ; Cohen MS; Leone PA
    N Engl J Med; 2005 May; 352(18):1873-83. PubMed ID: 15872202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BED estimates of HIV incidence: resolving the differences, making things simpler.
    Hargrove J; van Schalkwyk C; Eastwood H
    PLoS One; 2012; 7(1):e29736. PubMed ID: 22235334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IgG antibodies to human herpesvirus-6 (HHV-6) do not predict the progression of HIV disease to AIDS. Italian Seroconversion Study group.
    Dorrucci M; Rezza G; Andreoni M; Pezzotti P; Nicastri E; Ventura L; Zignani M; Alliegro MB; Tarantini G; Salassa B; Colangeli V; Mazzarello G; Ursitti MA; Barbanera M; Pristerà R; Castelli F; Ortona L
    Eur J Epidemiol; 1999 Apr; 15(4):317-22. PubMed ID: 10414371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.
    Schüpbach J; Gebhardt MD; Tomasik Z; Niederhauser C; Yerly S; Bürgisser P; Matter L; Gorgievski M; Dubs R; Schultze D; Steffen I; Andreutti C; Martinetti G; Güntert B; Staub R; Daneel S; Vernazza P
    PLoS Med; 2007 Dec; 4(12):e343. PubMed ID: 18052604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV incidence determination in the United States: a multiassay approach.
    Laeyendecker O; Brookmeyer R; Cousins MM; Mullis CE; Konikoff J; Donnell D; Celum C; Buchbinder SP; Seage GR; Kirk GD; Mehta SH; Astemborski J; Jacobson LP; Margolick JB; Brown J; Quinn TC; Eshleman SH
    J Infect Dis; 2013 Jan; 207(2):232-9. PubMed ID: 23129760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme immunoassays (EIAs) for the detection of anti-Haemophilus ducreyi serum IgA, IgG, and IgM antibodies.
    Roggen EL; Hoofd G; Van Dyck E; Piot P
    Sex Transm Dis; 1994; 21(1):36-42. PubMed ID: 8140487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.